Mass Tort Signed Cases
Top Mass Tort for
Law Firms
We help law firms grow in active mass tort categories through stronger positioning, targeted campaign strategy, and acquisition support built around the torts generating the most attention right now.
Mass Tort Campaigns with Current Opportunity
Not every tort deserves equal attention. The strongest campaigns are typically the ones with a clear injury narrative, sustained public interest, and enough legal visibility to support meaningful marketing and intake activity.
Our current focus is on six categories that continue to stand out in the market. For firms trying to be more selective about where they invest time, budget, and operational capacity, this lineup represents some of the best current opportunities.
Asbestos Litigation
Mesothelioma
One of the most established mass tort categories, mesothelioma offers strong case value and consistent demand from individuals and families seeking representation.
PHARMACEUTICAL LITIGATION
Depo-Provera
Long-term use and severe injury allegations have made Depo-Provera a major area of interest for firms expanding their tort practice.
PRODUCT LIABILITY
Hair Relaxer
One of the most visible product liability categories, with strong public familiarity and emotional resonance behind the claim story.
GLP-1 PHARMACEUTICAL LITIGATION
Ozempic
Public awareness of GLP-1 medications continues to drive consumer response and strong campaign performance.
SERIOUS INJURY & ASSAULT
Rideshare Sex Abuse Cases
Rideshare assault claims involve familiar platforms and serious allegations, creating strong public response and clear urgency.
DIGITAL HARM & PLATFORM LIABILITY
Roblox
As scrutiny of online safety and platform responsibility grows, Roblox-related claims have become a notable category for firms tracking emerging torts.
Other Mass Tort Litigation We Support
In addition to these core campaigns, we support a wider range of mass tort litigation categories. If your firm is focused on other pharmaceutical, product liability, environmental, or digital harm torts, we can align our strategy and acquisition approach with your specific priorities.
Our role is to help you concentrate on the torts that matter most to your practice while building an acquisition strategy that fits your intake structure, geographic footprint, and growth targets.
Compliance Architecture
Built for the 2026 Regulatory
Environment
Your license is your most valuable asset. Our platform is engineered to protect it – aligned with State Bar mandates and state laws regulating the purchasing of leads.
Anti-Barratry & Solicitation Safe
No runners, cold-callers, or scraped lists. All claimants are generated via inbound marketing where the user actively solicits information.
Transparent Advertising
Our campaigns are not blind. Claimants know they are engaging with legal advertising, satisfying clear and conspicuous disclosure standards.
No Fee-Splitting
We work on a marketing retainer or cost-per-acquisition basis. We never take a percentage of the settlement.
Limited Firm Participation
We cap the number of participating firms per tort to protect inventory quality and your competitive position.
Frequently Asked Questions
What mass tort dockets does MVPleads currently support?
MVPleads currently focuses on six active mass tort categories: mesothelioma and asbestos litigation, Depo-Provera pharmaceutical litigation, hair relaxer product liability, Ozempic and GLP-1 pharmaceutical litigation, rideshare sex abuse cases, and Roblox digital harm and platform liability claims. In addition to these core campaigns, MVPleads supports 13 or more additional MDL categories. Firms focused on other pharmaceutical, product liability, environmental, or digital harm torts can inquire about current availability.
How does MVPleads generate mass tort claimants?
All mass tort claimants are generated through inbound marketing where the claimant actively engages with legal advertising. No cold-calling, runners, or scraped lists are used. Campaigns are built with transparent advertising disclosures so claimants understand they are engaging with legal marketing. This structure satisfies anti-barratry and solicitation requirements and protects the firm's bar compliance position.
Does MVPleads deliver signed retainers for mass tort cases or just leads?
MVPleads delivers signed retainers for mass tort cases, not raw leads. The program is designed so your firm receives a fully executed retainer with a qualified claimant who has been screened against your medical and legal criteria. The intake process is handled by registered nurses trained in mass tort qualification, resulting in a 94% qualification accuracy rate.
How does MVPleads protect firms from bar compliance risk on mass tort campaigns?
MVPleads campaigns are structured as Joint Advertising programs aligned with state bar mandates and the regulations governing the purchase of leads in each jurisdiction. All claimants are inbound and consented. There is no fee splitting. MVPleads operates on a marketing retainer or cost per acquisition basis and never takes a percentage of any settlement. Advertising disclosures are clear and conspicuous. The program does not use cold-calling, runners, or any solicitation method that would trigger barratry exposure.
How does MVPleads limit competition between firms on the same docket?
MVPleads caps the number of participating firms per mass tort category. This protects inventory quality and ensures that firms in the program are not competing against each other for the same pool of claimants. When a category reaches capacity, no additional firms are onboarded for that docket.
What criteria determine whether a mass tort claimant qualifies?
Qualification criteria are specific to each tort and are established based on the medical and legal requirements of that litigation. For pharmaceutical cases, this typically includes documented use of the drug, injury timeline, diagnosis confirmation, and no prior legal representation. For product liability cases, criteria center on use of the specific product and documented injury. MVPleads works with each firm to align qualification criteria to their specific intake requirements before the campaign launches.
Why are some mass tort categories better opportunities than others?
The strongest mass tort campaigns have a clear injury narrative, sustained public interest, established legal visibility, and sufficient volume to support meaningful marketing and intake activity. Torts that lack one or more of these factors tend to produce inconsistent campaign performance and poor claimant response rates. MVPleads evaluates each docket against these criteria before recommending it to a firm, which is why the current focus list represents the categories with the strongest current opportunity.
How does a firm get started with a mass tort signed case campaign?
The first step is a strategy call to confirm which dockets are currently available, what the qualification criteria look like for your target case type, and what the cost per retainer is for that docket. MVPleads limits the number of firms per tort to protect inventory, so availability is reviewed on a first-come basis. Contact MVPleads at dave@mvpleads.ai or schedule a call at mvpleads.ai to confirm current availability before your category fills.
Don't Let Competitors Capture Your Docket?
The future of mass tort is data dominance. We limit participating firms per tort to protect inventory quality – reach out before your category fills.